Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 139-157

  Klibanov, Alexander L ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

Echo contrast; Microbubbles; Selective binding; Targeting; Ultrasound diagnostics; Ultrasound therapy

Indexed keywords

AGENTS; BIOCHEMISTRY; DIAGNOSTIC RADIOGRAPHY; DRUG THERAPY; MICROCIRCULATION; TISSUE; ULTRASONIC IMAGING;

CONTRAST AGENTS; ECHO CONTRAST; GAS FILLED MICROSPHERES; MICROBUBBLES; SELECTIVE BINDING; TARGETED DELIVERY; ULTRASOUND THERAPY;

CONTROLLED DRUG DELIVERY;

DEXTRAN; ECHO CONTRAST MEDIUM; FLUOROCARBON; MACROGOL; MICROSPHERE; POLYMER; POVIDONE; STARCH;

BLOOD CLOT LYSIS; CONTRAST; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; ECHOGRAPHY; ENDOTHELIUM CELL; GAS; GENE THERAPY; LIGAND BINDING; LIVER; PRIORITY JOURNAL; REVIEW; SPLEEN; TECHNIQUE; THROMBUS; TISSUE DISTRIBUTION; ULTRASOUND; ULTRASOUND THERAPY;

EID: 0344527887     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00104-5     Document Type: Review

References (76)

1. P.J. Ryan, M.A. Davis, D.L. Melchior, Liposomes containing modified cholesterol for organ targeting, US Patent 4544545, 1985.
2. H. Feigenbaum, J.M. Stone, D.A. Lee, W.K. Nasser, S. Chang, Identification of ultrasound echoes from the left ventricle by use of intracardiac injections of indocyanine green, Circulation 41 (1970) 615-621.
3. F.W. Kremkau, R. Gramiak, E.L. Carstensen, P.M. Shah, D. Kramer, Ultrasonic detection of cavitation at catheter tips, Am. J. Roentgenol. Radium Ther. Nucl. Med. 110 (1970) 177-183.
4. M.W. Keller, S.B. Feinstein, R.A. Briller, S.M. Powsner, Automated production and analysis of echo contrast agents, J. Ultrasound Med. 5 (1986) 493-498.
5. M.J. Cooper, D. Bernstein, N.H. Silverman, Recognition of left coronary artery fistula to the left and right ventricles by contrast echocardiography, J. Am. Coll. Cardiol. 6 (1985) 923-926.
6. F.W. Kremkau, Diagnostic Ultrasound, WB Saunders, Philadelphia.
7. R. Wildt, Physics of Sounds in the Sea. Part IV. Acoustic Properties of Wakes, Gordon and Breach, New York, 1968.
8. H. Alkan-Onyuksel, S.M. Demos, G.M. Lanza, M.J. Vonesh, M.E. Klegerman, B.J. Kane, J. Kuszak, D.D. McPherson, Development of inherently echogenic liposomes as an ultrasonic contrast agent, J. Pharm. Sci. 85 (1996) 486-490.
9. M. Behan, D. O'Connell, R.F. Mattrey, D.N. Carney, Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results, Am. J. Roentgenol. 160 (1993) 399-405.
10. G.M. Lanza, K.D. Wallace, M.J. Scott, W.P. Cacheris, D.R. Abendschein, D.H. Christy, A.M. Sharkey, J.G. Miller, P.J. Gaffney, S.A. Wickline, A novel site-targeted ultrasonic contrast agent with broad biomedical application, Circulation 94 (1996) 3334-3340.
11. N. de Jong, Acoustic Properties of Ultrasound Contrast Agents, Dissertation, Erasmus University, Rotterdam, 1993.
12. T.G. Leighton, The Acoustic Bubble, Academic Press, London, 1994.
13. M.A. Wheatley, B. Schrope, P. Shen, Contrast agents for diagnostic ultrasound: development and evaluation of polymer-coated microbubbles, Biomaterials 11 (1990) 713-717.
14. M. Schneider, P. Bussat, M.B. Barrau, M. Arditi, F. Yan, E. Hybl, Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin, Invest. Radiol. 27 (1992) 134-139.
15. M.W. Keller, S.B. Feinstein, D.D. Watson, Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation, Am. Heart J. 114 (1987) 570-575.
16. T. Fritzsch, J. Hilmann, M. Kampfe, N. Muller, C. Schobel, J. Siegert, SHU 508, a transpulmonary echocontrast agent: initial experience, Invest. Radiol. 25(Suppl. 1) (1990) S160-S161.
17. E.C. Unger, P.J. Lund, D.K. Shen, T.A. Fritz, D. Yellowhair, T.E. New, Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation, Radiology 185 (1992) 453-456.
18. J.R. Shapiro, S.A. Reisner, A.F. Amico, P.F. Kelly, R.S. Meltzer, Reproducibility of quantitative myocardial contrast echocardiography, J. Am. Coll. Cardiol. 15 (1990) 602-609.
19. S. Gottlieb, A. Ernst, R.S. Meltzer, Effect of pressure on echocardiographic videodensity from sonicated albumin: an in vitro model, J. Ultrasound Med. 14 (1995) 109-116.
20. J.H. Wible Jr., J.K. Wojdyla, G.L. Bales, W.N. McMullen, E.A. Geiser, D.D. Buss, Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs, J. Am. Soc. Echocardiogr. 9 (1996) 442-451.
21. D.P. Swanson, Enhancement agents for ultrasound: fundamentals, in: D.P. Swanson, H.M. Chilton, J.H. Thrall (Eds.), Pharmaceuticals in Medical Imaging. Radiopaque Contrast Media, Radiopharmaceuticals, Enhancement Agents for Magnetic Resonance Imaging and Ultrasound, Macmillan, New York, pp. 682-687.
22. T.A. Fritz, E.C. Unger, G. Sutherland, D. Sahn, Phase I clinical trials of MRX-115, a new ultrasound contrast agent, Invest. Radiol. 32 (1997) 735-740.
23. D.M. Skyba, G. Camarano, N.C. Goodman, R.J. Price, T.C. Skalak, S. Kaul, Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection, J. Am. Coll. Cardiol. 28 (1996) 1292-1300.
24. T.J. Pelura, Clinical experience with AFO150 (Imagent US), a new ultrasound contrast agent, Acad. Radiol. 5(Suppl. 1) (1998) S69-S71.
25. M. Schneider, M. Arditi, M.B. Barrau, J. Brochot, A. Broillet, R. Ventrone, F. Yan, BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles, Invest. Radiol. 30 (1995) 451-457.
26. C. Christiansen, H. Kryvi, P.C. Sontum, T. Skotland, Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin, Biotechnol. Appl. Biochem. 19 (1994) 307-320.
27. T. Fritzsch, D. Heldemann, W. Weitschies, Microparticle preparations made from biodegradable copolymers, World Patent WO 94/07539, 1994.
28. F.S. Villanueva, R.J. Jankowski, S. Klibanov, M.L. Pina, S.M. Alber, S.C. Watkins, G.H. Brandenburger, W.R. Wagner, Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells, Circulation 98 (1998) 1-5.
29. G.T. Hermanson, Bioconjugate Techniques, Academic Press, San Diego, 1995.
30. F.S. Villanueva, R.J. Jankowski, C. Manaugh, W. Wagner, Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography, J. Am. Coll. Cardiol. 30 (1997) 689-693.
31. H.D. Van Liew, S. Raychaudhuri, Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization, J. Appl. Physiol. 82 (1997) 2045-2053.
32. A.L. Klibanov, M.S. Hughes, J.N. Marsh, C.S. Hall, J.G. Miller, J.H. Wible, G.H. Brandenburger, Targeting of ultrasound contrast material. An in vitro feasibility study, Acta Radiol. 412(Suppl. 1) (1997) 113-120.
33. A.L. Klibanov, M.S. Hughes, J.K. Wojdyla, J.N. Marsh, C.S. Hall, J.G. Miller, J.H. Wible Jr., G.H. Brandenburger, Targeting of ultrasound contrast material: selective imaging of microbubbles in vitro, Acad. Radiol. 5(Suppl. 1) (1998) S243-S246.
34. L. Illum, S.S. Davis, The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338), FEBS Lett. 167 (1984) 79-82.
35. J. Hillman, L. Lange, I. Zimmermann, Ultrasonic contrast medium containing microparticles and gas bubbles, European Patent Application 122624, 1984.
36. D. Cassak, Point biomedical: planning for uncertainty, In vivo: Bus. Med. Rep. 16 (1998) 26-32.
37. A.L. Killam, P.M. Mehlhaff, B.A. McFerran, C.G. Burrascano, M.T. Kuvelas, J.A. Miller, Y. Greener, D.E. McClure, H.C. Dittrich, In vivo kinetics of the perfluoropropane component of FS069, a novel ultrasound contrast agent, in the anesthetized canine. Int. J. Toxicol. (1998) in press.
38. M. Blomley, T. Albrecht, D. Cosgrove, V. Jayaram, J. Butler-Barnes, R. Eckersley, Stimulated acoustic emission in liver parenchyma with Levovist, Lancet 351 (1998) 568.
39. C. Albayrak, Standardization of the measurement of acoustic properties of ultrasound contrast agents, Adv. Echo Contrast 5 (1997) 16-17.
40. S.A. Mousa, J.M. Bozarth, S. Edwards, T. Carroll, J. Barrett, Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis, Coron. Artery Dis. 9 (1998) 131-141.
41. K.Y. Hui, E. Haber, G.R. Matsueda, Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen, Science 222 (1983) 1129-1132.
42. S.M. Demos, H. Onyuksel, J. Gilbert, S.I. Roth, B. Kane, P. Jungblut, J.V. Pinto, D.D. McPherson, M.E. Klegerman, In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement, J. Pharm. Sci. 86 (1997) 167-171.
43. W.H. Wright, T.P. McCreery, E.A. Krupinski, P.J. Lund, S.H. Smyth, M.R. Baker, R.L. Hulett, E.C. Unger, Evaluation of new thrombus-specific ultrasound contrast agent, Acad. Radiol. 5 (1998) S240-S242.
44. E.C. Unger, T.P. McCreery, R.H. Sweitzer, D. Shen, G. Wu, In vitro studies of a new thrombus-specific ultrasound contrast agent, Am. J. Cardiol. 81 (1998) 58G-61G.
45. G. Molema, F.M.H. de Leij, D.K.F. Meijer, Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy, Pharm. Res. 14 (1997) 2-10.
46. M.I. Cubylsky, M.A. Gimbrone, Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, Science 251 (1991) 788-791.
47. P. Walday, H. Tolleshaug, T. Gjoen, G.M. Kindberg, T. Berg, T. Skotland, E. Holtz, Biodistributions of air-filled albumin microspheres in rats and pigs, Biochem. J. 299 (1994) 437-443.
48. O.A. Rosenberg, K.P. Hanson, E.A. Zherbin, Radiopaque liposomes for imaging of the spleen and liver, Radiology 149 (1983) 877-878.
49. C. Tilcock, E. Unger, P. Cullis, P. MacDougall, Liposomal Gd-DTPA: preparation and characterization of relaxivity, Radiology 171 (1989) 77-80.
50. P. Hauff, T. Fritzsch, M. Reinhardt, W. Weitschies, F. Luders, V. Uhlendorf, D. Heldmann, Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission, Invest. Radiol. 32 (1997) 94-99.
51. T.M. Allen, P. Williamson, R.A. Schlegel, Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface, Proc. Natl. Acad. Sci. USA 85 (1988) 8067-8071.
52. A.L. Klibanov, K. Maruyama, A.M. Beckerleg, V.P. Torchilin, L. Huang, The activity of amphipathic poly-ethyleneglycol to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target, Biochim. Biophys. Acta 1062 (1991) 142-148.
53. T. Nada, F. Moriyasu, Y. Kono, T. Matsumura, Sonographic depiction of woodchuck hepatomas using intravenously injected contrast agents, Nippon Rinsho (Japan) 56 (1998) 980-984.
54. R.J. Melder, L.L. Munn, S. Yamada, C. Ohkubo, R.K. Jain, Selectin- and integrin-mediated T-lymphocyte rolling and arrest on TNF-alpha-activated endothelium: augmentation by erythrocytes, Biophys. J. 69 (1995) 2131-2138.
55. G.P. Samokhin, M.D. Smirnov, V.R. Muzykantov, S.P. Domogatsky, V.N. Smirnov, Effect of flow rate and blood cellular elements on the efficiency of red blood cell targeting to collagen-coated surfaces, J. Appl. Biochem. 6 (1984) 70-75.
56. V.N. Smirnov, S.P. Domogatsky, V.V. Dolgov, V.B. Hvatov, A.L. Klibanov, V.E. Koteliansky, V.R. Muzykantov, V.S. Repin, G.P. Samokhin, BY Shekhonin, M.D. Smirnov, D.D. Sviridov, V.P. Torchilin, E.I. Chazov, Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall, Proc. Natl. Acad. Sci. USA 83 (1986) 6603-6607.
57. V.S. Trubetskoy, V.R. Berdichevsky, E.E. Efremov, V.P. Torchilin, On the possibility of the unification of drug targeting systems. Studies with liposome transport to the mixtures of target antigens, Biochem. Pharmacol. 36 (1987) 839-842.
58. R.A. Wray, M.A. Quinones, W.A. Zoghbi, J.B. Cheirif, Relation of mean pixel intensity to concentration of sonicated albumin microspheres: effects of ultrasound system settings, Clin. Cardiol. 14(Suppl. V) (1991) V23-V28.
59. T.R. Porter, L. Shouping, D. Kricsfeld, R.W. Armbruster, Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging, J. Am. Coll. Cardiol. 29 (1997) 791-799.
60. K. Wei, A.R. Jayaweera, S. Firoozan, A. Linka, D.M. Skyba, S. Kaul, Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion, Circulation 97 (1998) 473-483.
61. A.L. Klibanov, K.W. Ferrara, M.S. Hughes, J.H. Wible, J.K. Wojdyla, P.A. Dayton, K. Morgan, G.H. Brandenburger, Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres. Invest. Radiol. (1998) in press.
62. D. Dalecki, C.H. Raeman, S.Z. Child, D.P. Penney, R. Mayer, E.L. Carstensen, The influence of contrast agents on hemorrhage produced by lithotripter fields, Ultrasound Med. Biol. 23 (1997) 1435-1439.
63. D. Dalecki, C.H. Raeman, S.Z. Child, C. Cox, C.W. Francis, R.S. Meltzer, E.L. Carstensen, Hemolysis in vivo from exposure to pulsed ultrasound, Ultrasound Med. Biol. 23 (1997) 307-313.
64. C.R. Hill, G.R. ter Haar, Review article: high intensity focused ultrasound -potential for cancer treatment, Br. J. Radiol. 68 (1995) 1296-1303.
65. H. Luo, W. Steffen, B. Cercek, S. Arunasalam, G. Maurer, R.J. Siegel, Enhancement of thrombolysis by external ultrasound, Am. Heart J. 125 (1993) 1564-1569.
66. H.J. Kim, J.F. Greenleaf, R.R. Kinnick, J.T. Bronk, M.E. Bolander, Ultrasound-mediated transfection of mammalian cells, Hum. Gene Ther. 7 (1996) 1339-1346.
67. S. Mitragotri, D. Blankschtein, R. Langer, An explanation for the variation of the sonophoretic transdermal transport enhancement from drug to drug, J. Pharm. Sci. 86 (1997) 1190-1192.
68. W.J. Greenleaf, M.E. Bolander, G. Sarkar, M.B. Goldring, J.F. Greenleaf, Artificial cavitation nuclei significantly enhance acoustically induced cell transfection, Ultrasound Med. Biol. 24 (1998) 587-595.
69. B.B. Goldberg, F. Forsberg, Contrast-enhanced ultrasound imaging, Sci. Med. No. 3 (1998) 54-63.
70. E.C. Unger, T. McCreery, R. Sweitzer, G. Vielhauer, G. Wu, D. Shen, D. Yellowhair, MRX 501: a novel ultrasound contrast agent with therapeutic properties, Acad. Radiol. 5(Suppl. 1) (1998) S247-S249.
71. K. Tachibana, S. Tachibana, Albumin microbubble echocontrast material as an enhancer for ultrasound accelerated thrombolysis, Circulation 92 (1995) 1148-1150.
72. T.R. Porter, R.F. LeVeen, R. Fox, A. Kricsfeld, F. Xie, Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles, Am. Heart J. 132 (1996) 964-968.
73. E.C. Unger, T.P. McCreery, R.H. Sweitzer, Ultrasound enhances gene expression of liposomal transfection, Invest. Radiol. 32 (1997) 723-727.
74. S. Bao, B.D. Thrall, D.L. Miller, Transfection of a reporter plasmid into cultured cells by sonoporation in vitro, Ultrasound Med. Biol. 23 (1997) 953-959.
75. E.C. Unger, T.A. Fritz, T. Matsunaga, V.R. Ramaswami, D. Yellowhair, G. Wu, Therapeutic drug delivery systems, US Patent 5770222, 1998.
76. T.R. Porter, P.L. Iversen, S.P. Li, F. Xie, Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles, J. Ultrasound Med. 15 (1996) 577-584.